NDC 0409-3510

Ertapenem

Ertapenem

Ertapenem is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Ertapenem Sodium.

Product ID0409-3510_178a0356-4f6c-47fb-9913-f325a3c72f7b
NDC0409-3510
Product TypeHuman Prescription Drug
Proprietary NameErtapenem
Generic NameErtapenem
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2020-10-19
Marketing CategoryANDA / ANDA
Application NumberANDA208790
Labeler NameHospira, Inc.
Substance NameERTAPENEM SODIUM
Active Ingredient Strength1 g/1
Pharm ClassesCarbapenems [CS],Penem Antibacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0409-3510-22

10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3510-22) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-3510-21)
Marketing Start Date2020-10-19
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Ertapenem" or generic name "Ertapenem"

NDCBrand NameGeneric Name
0409-3510ErtapenemErtapenem
42023-221ERTAPENEMertapenem sodium
44567-820ertapenemertapenem
44647-051ErtapenemErtapenem Sodium
55150-282ErtapenemErtapenem
60505-6196ErtapenemErtapenem Sodium
63323-823ErtapenemErtapenem Sodium
68001-408ErtapenemErtapenem Sodium
68083-351ErtapenemErtapenem Sodium
16714-889ERTAPENEM SODIUMErtapenem
43598-901ERTAPENEM SODIUMErtapenem

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.